Literature DB >> 9259270

Behaviour of a population of partially duplicated mitochondrial DNA molecules in cell culture: segregation, maintenance and recombination dependent upon nuclear background.

I J Holt1, D R Dunbar, H T Jacobs.   

Abstract

We have studied the dynamics of mitochondrial DNA maintenance and segregation in human cells using serial cybrid transfer of partially duplicated mitochondrial DNA, from a mitochondrial myopathy patient, to two distinct recipient cell types. The results indicate two radically different outcomes dependent upon nuclear background. In one case (lung carcinoma) there is systematic loss of the partial duplication by an implied recombinational mechanism. In another nuclear background (osteosarcoma) the duplicated molecules can survive, having only a marginal effect on mitochondrial respiratory function. Moreover, in the osteosarcoma nuclear background further disturbances of mtDNA maintenance frequently follow from cybrid transfer. These are progressive, catastrophic loss of mtDNA and further rearrangement to generate partially triplicated molecules. The results imply differential expression of nuclear genes regulating mtDNA copy number, replication and recombination in different human cell types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259270     DOI: 10.1093/hmg/6.8.1251

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

1.  Analysis of repeat-mediated deletions in the mitochondrial genome of Saccharomyces cerevisiae.

Authors:  Naina Phadnis; Rey A Sia; Elaine A Sia
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

2.  Co-segregation and heteroplasmy of two coding-region mtDNA mutations within a matrilineal pedigree.

Authors:  Neil Howell; Iwona Kubacka; Sharon M Keers; Douglass M Turnbull; Patrick F Chinnery
Journal:  Hum Genet       Date:  2004-11-03       Impact factor: 4.132

Review 3.  Mechanism of homologous recombination and implications for aging-related deletions in mitochondrial DNA.

Authors:  Xin Jie Chen
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 4.  Mitochondrial genetics '98 is the bottleneck cracked?

Authors:  J Poulton; V Macaulay; D R Marchington
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

Review 5.  Minimizing the damage: repair pathways keep mitochondrial DNA intact.

Authors:  Lawrence Kazak; Aurelio Reyes; Ian J Holt
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

6.  Rearrangements of human mitochondrial DNA (mtDNA): new insights into the regulation of mtDNA copy number and gene expression.

Authors:  Y Tang; E A Schon; E Wilichowski; M E Vazquez-Memije; E Davidson; M P King
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

7.  Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA.

Authors:  Adriana Malena; Boris Pantic; Doriana Borgia; Gianluca Sgarbi; Giancarlo Solaini; Ian J Holt; Antonella Spinazzola; Egle Perissinotto; Marco Sandri; Alessandra Baracca; Lodovica Vergani
Journal:  Autophagy       Date:  2016-09-14       Impact factor: 16.016

Review 8.  Intracellular quality control of mitochondrial DNA: evidence and limitations.

Authors:  Dmitry A Knorre
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-12-02       Impact factor: 6.237

9.  Mitochondrial genome haplotype hypervariation within the isopod parasitic nematode Thaumamermis cosgrovei.

Authors:  Sha Tang; Bradley C Hyman
Journal:  Genetics       Date:  2007-04-15       Impact factor: 4.562

10.  Human heart mitochondrial DNA is organized in complex catenated networks containing abundant four-way junctions and replication forks.

Authors:  Jaakko L O Pohjoismäki; Steffi Goffart; Henna Tyynismaa; Smaranda Willcox; Tomomi Ide; Dongchon Kang; Anu Suomalainen; Pekka J Karhunen; Jack D Griffith; Ian J Holt; Howard T Jacobs
Journal:  J Biol Chem       Date:  2009-06-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.